Biomarkers: The Neurodegenerative Disease Game Changer Webinar

Upcoming Webinar on Tuesday, February 25, 2025 at 15:00 GMT / 16:00 CET / 10:00 EST / 7:00 PST 

What's the webinar about?

Biomarkers are essential indicators found in body fluids or tissues that help diagnose, prognose, and monitor diseases, enabling personalized treatments. In neurodegenerative diseases like Alzheimer's, ALS, Parkinson's, and TBI, biomarkers are crucial for early detection and understanding disease progression. 

Our webinar will explore key biomarkers such as Neurofilament Light (NfL), Glial Fibrillary Acidic Protein (GFAP), and Tau proteins, highlighting their role in early diagnosis and treatment response. 

Discussion points:  

• Biomarkers 

• Neurodegenerative diseases 

• Biomarkers for neurodegenerative diseases and conditions 

• Diagnostics of biomarkers 

• Medix Biochemica Neurology portfolio 

• Alzheimer’s disease, traumatic brain injury (TBI), Parkinson’s disease, ALS, Multiple sclerosis

Key take aways: 

• Early Detection: Biomarkers can aid in the early detection of neurodegenerative diseases, enabling timely intervention and better patient outcomes. 

• Understanding Disease Mechanisms: Biomarkers help in understanding the progression of neurodegenerative diseases, crucial for developing effective treatments. 

• Medix Biochemica's Neurology Portfolio: Medix Biochemica will showcase our high-quality neurology antibodies, antigens, and biospecimens, including new products essential for advancing research and clinical applications.